TAM JAI INTL(02217) mid-term profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Tanzi International (02217) announced that for the six months ended September 30, 2024, it achieved revenue of 1.404 billion...
TAM JAI INTL (02217) announced that, for the six months ended September 30, 2024, the company achieved revenue of 1.404 billion Hong Kong dollars, an increase of 1.23% year-on-year; the net profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Related Articles
SIMCERE PHARMA (02096)SIM0613 (LRRC15 antibody drug conjugate) has obtained the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration.
Tianhai Electronics (001365.SZ) IPO price is 27.19 yuan per share, with subscription starting on May 7th.
Guotai Haitong: The food and beverage industry continues to differentiate, with mass market products leading the way in recovery, and the liquor industry undergoing deep adjustment.
SIMCERE PHARMA (02096)SIM0613 (LRRC15 antibody drug conjugate) has obtained the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration.
Tianhai Electronics (001365.SZ) IPO price is 27.19 yuan per share, with subscription starting on May 7th.
Guotai Haitong: The food and beverage industry continues to differentiate, with mass market products leading the way in recovery, and the liquor industry undergoing deep adjustment.
